RTW INVESTMENTS, LP - 26 Jan 2021 Form 4 Insider Report for DermTech, Inc.

Role
10%+ Owner
Signature
RTW Investments, LP, By: /s/ Roderick Wong, Managing Partner
Issuer symbol
N/A
Transactions as of
26 Jan 2021
Net transactions value
-$176,660
Form type
4
Filing time
08 Nov 2022, 16:19:32 UTC
Next filing
07 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMTK Common Stock Exercise of in-the-money or at-the-money derivative security $300,033 +31,450 +1% $9.54 3,118,666 26 Jan 2021 See footnote F1
transaction DMTK Common Stock Sale $176,660 -100,000 -3.2% $1.77 3,018,666 04 Nov 2022 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DMTK Warrants to Purchase Common Stock Exercise of in-the-money or at-the-money derivative security $300,033 -31,450 -100% $9.54 0 26 Jan 2021 Common Stock 31,450 $9.54 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

RTW INVESTMENTS, LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to the shares of common stock held by certain investment funds managed by the Adviser (the "RTW Funds") and (ii) Roderick Wong, M.D., who serves as the Managing Partner and Chief Investment Officer of the Adviser.

Remarks:

Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.